Your browser doesn't support javascript.
loading
Not all low grade dysplasia in Barrett's oesophagus is the same: using specific histological criteria in predicting progression to neoplasia.
Tsoi, Edward H; Williams, Richard A; Christie, Michael; Machet, David; Deb, Siddhartha; Sundararajan, Vijaya; Cameron, Georgina R; Desmond, Paul V; Taylor, Andrew C F.
Afiliação
  • Tsoi EH; St Vincent's Hospital Melbourne, Gastroenterology, Fitzroy, Vic, Australia; University of Melbourne, Faculty of Medicine, Dentistry and Health Sciences, Melbourne, Vic, Australia. Electronic address: Edward.tsoi@svha.org.au.
  • Williams RA; University of Melbourne, Faculty of Medicine, Dentistry and Health Sciences, Melbourne, Vic, Australia; St Vincent's Hospital Melbourne, Pathology, Fitzroy, Vic, Australia.
  • Christie M; The Royal Melbourne Hospital, Pathology, Parkville, Vic, Australia.
  • Machet D; Anatpath, Pathology, Gardenvale, Vic, Australia.
  • Deb S; Anatpath, Pathology, Gardenvale, Vic, Australia.
  • Sundararajan V; University of Melbourne, Faculty of Medicine, Dentistry and Health Sciences, Melbourne, Vic, Australia.
  • Cameron GR; St Vincent's Hospital Melbourne, Gastroenterology, Fitzroy, Vic, Australia.
  • Desmond PV; St Vincent's Hospital Melbourne, Gastroenterology, Fitzroy, Vic, Australia; University of Melbourne, Faculty of Medicine, Dentistry and Health Sciences, Melbourne, Vic, Australia.
  • Taylor ACF; St Vincent's Hospital Melbourne, Gastroenterology, Fitzroy, Vic, Australia; University of Melbourne, Faculty of Medicine, Dentistry and Health Sciences, Melbourne, Vic, Australia.
Pathology ; 53(6): 700-704, 2021 Oct.
Article em En | MEDLINE | ID: mdl-34420794
Barrett's oesophagus with low grade dysplasia (LGD) is a risk factor for progression to high grade dysplasia (HGD) and oesophageal adenocarcinoma (OAC); however, only a subgroup of LGD will progress. We used a combination of specific histological criteria to identify patients with LGD who are more likely to progress to HGD or OAC. LGD slides from 38 patients within the progressor group (PG) and 17 patients from the non-progressor group (NPG) were obtained and reviewed by two expert GI pathologists, to be stratified by the same four specific histological variables identified by Ten Kate et al.: loss of surface maturation, mucin depletion, nuclear enlargement, and increase of mitosis. After review of LGD slides by two expert GI pathologists, 27 suitable patients were identified. Of these 27 patients there was a higher proportion of patients from the PG with all four specific criteria reported, compared to the NPG: 14 (78%) vs 3 (33%) p=0.0394. Patients with all four specific criteria were more likely to progress compared to those who had one or less specific criteria reported (OR 7, 95% CI 1.1848-41.3585, p=0.032). A combination of ≥2 or ≥3 specific histological criteria was not prognostic. Patients with a combination of all four specific histological criteria (loss of surface maturation, mucin depletion, nuclear enlargement, and increase of mitosis) were associated with greater progression from LGD to HGD or OAC in Barrett's oesophagus.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lesões Pré-Cancerosas / Esôfago de Barrett / Neoplasias Esofágicas / Adenocarcinoma / Neoplasias Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lesões Pré-Cancerosas / Esôfago de Barrett / Neoplasias Esofágicas / Adenocarcinoma / Neoplasias Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article